Literature DB >> 30720141

Inflammatory and fibrosis infiltration in synovium associated with the progression in developmental dysplasia of the hip.

Hui Wang1, Ji-Ye He1, Cheng-Long Wang1, Wei-Jia Feng1, Chao Shen1, Jun-Feng Zhu1, Dong-Liang Wang1, Xiao-Dong Chen1.   

Abstract

Developmental dysplasia of the hip (DDH) is a common musculoskeletal disorder characterized by progressive joint soreness and limited mobility. The aim of the present study was to investigate the pathological changes and inflammatory infiltration in the hypertrophic synovium of the hip joint associated with the progression of DDH. Synovial biopsies in the hip joint are obtained from patients with moderate DDH and severe DDH during surgery. These biopsies are processed for histological and immunohistochemical (IHC) analysis and investigation of the pathological processes in a synovium, including types of inflammatory cell infiltration, synovial angiogenesis and fibrosis, neuron endings and neuropeptide invasion. Correlation analysis was performed between the mean optical density (MOD) of each antibody, and Harris hip score (HHS) and visual analogue score (VAS) using the Spearman correlation test. Chronic inflammation in the synovium was observed via the positive IHC staining of inflammatory cells, such as T cells, B cells, macrophages and leukocytes. Excessive staining of vimentin and α smooth muscle actin in the synovium of severe DDH represented significant fibrosis and angiogenesis. These targets were also significantly correlated with HHS in severe DDH. The MOD levels of CD68 (indicators of macrophage) indicated apparent correlations with HHS and VAS in patients with severe DDH. The labels of nerve fibers and pain transmission indicators were as follows: Neurofilament‑200 and substance P. Calcitonin gene‑related peptide was upregulated in the synovium of severe DDH in contrast to that in the synovium of moderate DDH. The MOD levels of NF‑200, SP and CGRP were correlated with VAS in severe DDH. The pathology of DDH includes chronic inflammatory cell infiltration corresponding with nerve fibers and fibroblastic proliferation, which might contribute to arthritis progression and joint soreness in DDH.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30720141     DOI: 10.3892/mmr.2019.9910

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  CEMIP (KIAA1199) regulates inflammation, hyperplasia and fibrosis in osteoarthritis synovial membrane.

Authors:  Michel G Malaise; Dominique de Seny; Céline Deroyer; Christophe Poulet; Geneviève Paulissen; Federica Ciregia; Olivier Malaise; Zelda Plener; Gaël Cobraiville; Christophe Daniel; Philippe Gillet
Journal:  Cell Mol Life Sci       Date:  2022-04-27       Impact factor: 9.207

2.  Macrophage migration inhibitory factor regulates joint capsule fibrosis by promoting TGF-β1 production in fibroblasts.

Authors:  Yuxin Zhang; Zhonglong Liu; Kexin Wang; Shenji Lu; Shuai Fan; Lili Xu; Bin Cai
Journal:  Int J Biol Sci       Date:  2021-04-29       Impact factor: 6.580

3.  Innervation of the hip joint capsular complex: A systematic review of histological and immunohistochemical studies and their clinical implications for contemporary treatment strategies in total hip arthroplasty.

Authors:  Joanna Tomlinson; Johann Zwirner; Benjamin Ondruschka; Torsten Prietzel; Niels Hammer
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

Review 4.  The Role of Fibrosis in Osteoarthritis Progression.

Authors:  Yeri Alice Rim; Ji Hyeon Ju
Journal:  Life (Basel)       Date:  2020-12-23

5.  Obesity and load-induced posttraumatic osteoarthritis in the absence of fracture or surgical trauma.

Authors:  Marysol Luna; Jason D Guss; Laura S Vasquez-Bolanos; Adrian J Alepuz; Sophie Dornevil; Jasmin Strong; Denise Alabi; Qiaojuan Shi; Tania Pannellini; Miguel Otero; Ilana L Brito; Marjolein C H van der Meulen; Steven R Goldring; Christopher J Hernandez
Journal:  J Orthop Res       Date:  2020-07-17       Impact factor: 3.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.